Home/CNBX Pharmaceuticals/Dr. Sanja Goldberg
DS

Dr. Sanja Goldberg

CTO

CNBX Pharmaceuticals

CNBX Pharmaceuticals Pipeline

DrugIndicationPhase
Cannabics® RCC-33Colorectal CancerPreclinical
Cannabics® MLN-33MelanomaPreclinical
Cannabics® BRST-33Breast CancerPreclinical
Cannabics® PRST-33Prostate CancerPreclinical
Cannabics® PLP-33Pre-cancerous PolypsPreclinical
Cannabics® SRCancer-related Anorexia Cachexia Syndrome (CACS)Phase 3
NP-01Neuropsychiatry (unspecified)Preclinical
NP-02Neuropsychiatry (unspecified)N/A